Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human”

1,164 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,164
Index total 30,257
Page 10 / 49

Quick answer

This filtered view shows 1,164 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,164 results for “The United States of America, as represented by the Secretary, Department of Health and Human” · 30,257 patents in full index Clear search

  1. US 11352365

    Biased potent opioid-like agonists as improved medications to treat chronic and acute pain and methods of using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  2. US 11352410

    Anti-KK-LC-1 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  3. US 11352435

    Anti-CD133 monoclonal antibodies and related compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  4. US 11344615

    Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in vero cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 31, 2022 · Expires May 26, 2042

    granted

  5. US 11339198

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2022 · Expires May 19, 2042

    granted

  6. US 11337971

    Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2022 · Expires May 19, 2042

    granted

  7. US 11338033

    Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2022 · Expires May 19, 2042

    granted

  8. US 11337988

    Use of ouabain antagonists to inhibit viral infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2022 · Expires May 19, 2042

    granted

  9. US 11331385

    Methods of preparing anti-human papillomavirus antigen T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2022 · Expires May 12, 2042

    granted

  10. US 11332721

    Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2022 · Expires May 12, 2042

    granted

  11. US 11325965

    Single-domain VH H antibodies directed to norovirus GI.1 and GII.4 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2022 · Expires May 5, 2042

    granted

  12. US 11324725

    Compositions and methods for the inhibition of pruritus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2022 · Expires May 5, 2042

    granted

  13. US 11318196

    Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  14. US 11306132

    HLA class II-restricted T cell receptors against mutated RAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  15. US 11305009

    Recombinant virus with diminished latency and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  16. US 11306131

    T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  17. US 11299546

    FLT3-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  18. US 11299476

    Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  19. US 11293010

    Methods of producing modified natural killer cells and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  20. US 11285142

    Compositions and methods for identifying and treating dystonia disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  21. US 11285169

    Methods for modulating chemotherapeutic cytotoxicity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  22. US 11278572

    Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  23. US 11273214

    Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  24. US 11266726

    Compositions and methods for the treatment of HER2-expressing solid tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.